NEVRO CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
NEVRO CORP. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $0 as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-03-04
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $87.00K.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $2.38M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $15.66M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-04 |
| 2023-12-31 | $87.00K 10-K · filed 2024-02-23 |
| 2022-12-31 | $2.38M 10-K · filed 2023-02-21 |
| 2021-12-31 | $15.66M 10-K · filed 2022-02-23 |
| 2020-12-31 | $69.09M 10-K · filed 2021-02-24 |
| 2019-12-31 | $79.19M 10-K · filed 2020-02-25 |
| 2018-12-31 | $21.87M 10-K · filed 2019-02-21 |
| 2017-12-31 | $58.83M 10-K · filed 2018-02-22 |
| 2016-12-31 | $87.36M 10-K · filed 2017-02-23 |
| 2015-12-31 | $84.75M 10-K · filed 2016-02-29 |
| 2014-12-31 | $51.71M 10-K · filed 2015-03-18 |